Cargando…

Congenital hyperinsulinism: current trends in diagnosis and therapy

Congenital hyperinsulinism (HI) is an inappropriate insulin secretion by the pancreatic β-cells secondary to various genetic disorders. The incidence is estimated at 1/50, 000 live births, but it may be as high as 1/2, 500 in countries with substantial consanguinity. Recurrent episodes of hyperinsul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnoux, Jean-Baptiste, Verkarre, Virginie, Saint-Martin, Cécile, Montravers, Françoise, Brassier, Anaïs, Valayannopoulos, Vassili, Brunelle, Francis, Fournet, Jean-Christophe, Robert, Jean-Jacques, Aigrain, Yves, Bellanné-Chantelot, Christine, de Lonlay, Pascale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199232/ https://www.ncbi.nlm.nih.gov/pubmed/21967988 http://dx.doi.org/10.1186/1750-1172-6-63

Ejemplares similares

Familial Focal Congenital Hyperinsulinism
por: Ismail, Dunia, et al.
Publicado: (2011)

Glucose Metabolism in 105 Children and Adolescents After Pancreatectomy for Congenital Hyperinsulinism
por: Beltrand, Jacques, et al.
Publicado: (2012)

Mutations in UCP2 in Congenital Hyperinsulinism Reveal a Role for Regulation of Insulin Secretion
por: González-Barroso, M. Mar, et al.
Publicado: (2008)

In Vitro Recovery of ATP-Sensitive Potassium Channels in β-Cells From Patients With Congenital Hyperinsulinism of Infancy
por: Powell, Philippa D., et al.
Publicado: (2011)

Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients
por: Brassier, Anais, et al.
Publicado: (2015)

Update of variants identified in the pancreatic β‐cell K(ATP) channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes
por: De Franco, Elisa, et al.
Publicado: (2020)

Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
por: Banerjee, Indraneel, et al.
Publicado: (2022)

Citrulline in the management of patients with urea cycle disorders
por: Imbard, Apolline, et al.
Publicado: (2023)

Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
por: Banerjee, Indraneel, et al.
Publicado: (2022)

Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias
por: Nizon, Mathilde, et al.
Publicado: (2013)

Long-term renal outcome in methylmalonic acidemia in adolescents and adults
por: Dao, Myriam, et al.
Publicado: (2021)

Glucocorticoid-Induced Hyperinsulinism in a Preterm Neonate with Inherited ABCC8 Variant
por: Motte-Signoret, Emmanuelle, et al.
Publicado: (2022)

Congenital neutropenia: diagnosis, molecular bases and patient management
por: Donadieu, Jean, et al.
Publicado: (2011)

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
por: Wicker, Camille, et al.
Publicado: (2020)

Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study
por: Husson, Marie-Caroline, et al.
Publicado: (2016)

Real‐world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid‐free formulas in France and Germany: A retrospective observational study
por: de Lonlay, Pascale, et al.
Publicado: (2021)

Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges
por: Timsit, José, et al.
Publicado: (2022)

Enteral tube feeding in patients receiving dietary treatment for metabolic diseases: A retrospective analysis in a large French cohort
por: Bérat, Claire-Marine, et al.
Publicado: (2021)

Global Registries in Congenital Hyperinsulinism
por: Pasquini, Tai L. S., et al.
Publicado: (2022)

Syndromic forms of congenital hyperinsulinism
por: Zenker, Martin, et al.
Publicado: (2023)

Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up
por: Demaret, Tanguy, et al.
Publicado: (2021)

Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening
por: Hajji, Hela, et al.
Publicado: (2022)

Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism
por: Raskin, Julie, et al.
Publicado: (2022)

Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study
por: Alili, Jean-Meidi, et al.
Publicado: (2022)

FGF10 Signaling differences between type I pleuropulmonary blastoma and congenital cystic adenomatoid malformation
por: Lezmi, Guillaume, et al.
Publicado: (2013)

Sirolimus treatment of severe congenital hyperinsulinism
por: Amato, Lisa A, et al.
Publicado: (2015)

A Case Series: Congenital Hyperinsulinism
por: Alaei, Mohammad Reza, et al.
Publicado: (2016)

Congenital Hyperinsulinism: Diagnosis and Treatment Update
por: Demirbilek, Hüseyin, et al.
Publicado: (2017)

The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism
por: Galcheva, Sonya, et al.
Publicado: (2019)

Clinical practice guidelines for congenital hyperinsulinism
por: Yorifuji, Tohru, et al.
Publicado: (2017)

Congenital Hyperinsulinism Caused by Hexokinase I Expression or Glucokinase-Activating Mutation in a Subset of β-Cells
por: Henquin, Jean-Claude, et al.
Publicado: (2013)

Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study
por: Jones, Simon A., et al.
Publicado: (2017)

Congenital hyperinsulinism: current status and future perspectives
por: Yorifuji, Tohru
Publicado: (2014)

The molecular mechanisms, diagnosis and management of congenital hyperinsulinism
por: Senniappan, Senthil, et al.
Publicado: (2013)

Nifedipine in Congenital Hyperinsulinism- A Case Report
por: Khawash, Papiya, et al.
Publicado: (2015)

Therapies and outcomes of congenital hyperinsulinism‐induced hypoglycaemia
por: Banerjee, I., et al.
Publicado: (2018)

Possible New Strategies for the Treatment of Congenital Hyperinsulinism
por: Sikimic, Jelena, et al.
Publicado: (2020)

Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism
por: Hashemian, Somayyeh, et al.
Publicado: (2020)

Somatostatin receptors in congenital hyperinsulinism: Biology to bedside
por: van Albada, Mirjam E., et al.
Publicado: (2022)

Congenital hyperinsulinism and panhypopituitarism: a rare combination
por: Patel, Foram, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ve214nk8kddnglam3cd47ruv2i